FDA Clearance Tracker · P190023-S020
FlexNav and Navitor Loading System, FlexNav Delivery System
Last checked: Nov 20, 2026Latest source record: Oct 1, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 1, 2024
Approved
Time to decision
71 days
Received Jul 22, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P190023-S020
- Device name
- FlexNav and Navitor Loading System, FlexNav Delivery System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Jul 22, 2024
- Decided
- Oct 1, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P190023
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
the addition of Centerpiece Tijuana Mexico as an alternative Ethylene Oxide (EO) sterilization facility for the sterilization of the provided devices in scope approved under the PMA/HDE numbers P000039, P02004, P200049, P120021, P040040, H070005, P190023
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.